Default company panoramic image
4c50b083 03b2 46f6 abeb 0b4553fca3f4

GLSynthesis Inc.

GLSynthesis Inc. is a drug discovery company focusing on anti-infective and antithrombotic drugs.

  • Stage $5M in TTM Revenue
  • Industry Biotechnology
  • Location Worcester, MA, USA
  • Currency USD
  • Founded June 1996
  • Employees 16
  • Incorporation Type C-corp
  • Website glsynthesis.com

Company Summary

GLSynthesis Inc. has established a drug discovery service business (custom organic synthesis, analytical chemistry and rodent pharmacology) to provide compounds and services to pharmaceutical and biotechnology companies and research institutions, and to carry out drug and chemical product R&D through corporate contracts and small business grants.

Team

  • Default avatar
    Ivan Borrisov Yanachkov
    CSO

    M.S. (1980) and Ph.D. (1987), University of Chemical Technology and Metallurgy, Sofia, Bulgaria. Ph.D. in Chemistry (1996), Clark University, Worcester, MA. Senior Scientist, Drug Innovation and Design, Waltham, MA. Senior Scientist, GLSynthesis, Worcester, MA. Accomplished nucleoside/tide chemist and analyst. Director of Quality Control at GLSynthesis Inc. He leads antithrombotic drug synthesis and development.

  • Default avatar
    George Edward Wright
    CEO

    B.S in pharmacy, 1963; Ph.D. in pharmaceutical chemistry, 1967. Professor of Pharmacology, University of Massachusetts Medical School, 1974-96.

Advisors

  • Default avatar
    Jeff Donaldson, Mirick O'Connell
    Lawyer
    Unconfirmed
    Default avatar
    Chuck Swartz, Swartz Polachek & Co.
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    none
    Unconfirmed